Bausch Health Companies Inc. [BHC] moved down -0.65: Why It’s Important


Bausch Health Companies Inc. [NYSE: BHC] stock went on a downward path that fall over -0.65% on Monday, amounting to a one-week price decrease of less than -16.51%. The company report on May 11, 2022 that Bausch Health Announces Participation In Upcoming Investor Conferences.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


– Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) today announced that the Company will participate in several upcoming investor conferences.

Tom Vadaketh, executive vice president and chief financial officer; William Woodfield, senior vice president and treasurer; and Christina Cheng, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the 7th Annual Goldman Sachs Leveraged Finance and Credit Conference in Long Beach, Calif. on May 12, 2022 at 9:05 a.m. PT and at the Barclays High Yield Bond & Syndicated Loan Conference in Austin, Texas on May 24, 2022 at 11:00 a.m. CT.

Over the last 12 months, BHC stock dropped by -63.18%.

The market cap for the stock reached $3.76 billion, with 360.80 million shares outstanding and 346.27 million shares in the current float. Compared to the average trading volume of 5.80M shares, BHC stock reached a trading volume of 7077886 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Bausch Health Companies Inc. [BHC]:

BofA Securities have made an estimate for Bausch Health Companies Inc. shares, keeping their opinion on the stock as Underperform, with their previous recommendation back on March 24, 2021. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price from $26 to $42. The new note on the price target was released on February 17, 2021, representing the official price target for Bausch Health Companies Inc. stock. Previously, the target price had yet another raise from $25 to $30, while Piper Sandler kept a Neutral rating on BHC stock.

The Average True Range (ATR) for Bausch Health Companies Inc. is set at 1.35, with the Price to Sales ratio for BHC stock in the period of the last 12 months amounting to 0.45. Price to Free Cash Flow for BHC in the course of the last twelve months was 5.60 with Quick ratio for the last quarter at 1.00.

BHC Stock Performance Analysis:

Bausch Health Companies Inc. [BHC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -16.51. With this latest performance, BHC shares dropped by -51.42% in over the last four-week period, additionally sinking by -59.27% over the last 6 months – not to mention a drop of -63.18% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BHC stock in for the last two-week period is set at 19.23, with the RSI for the last a single of trading hit 18.15, and the three-weeks RSI is set at 21.75 for Bausch Health Companies Inc. [BHC]. The present Moving Average for the last 50 days of trading for this stock 20.57, while it was recorded at 10.32 for the last single week of trading, and 25.15 for the last 200 days.

Insight into Bausch Health Companies Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Bausch Health Companies Inc. [BHC] shares currently have an operating margin of +18.69 and a Gross Margin at +55.31. Bausch Health Companies Inc.’s Net Margin is presently recorded at -11.24.

Return on Equity for this stock declined to -441.96, with Return on Assets sitting at -3.14.

Bausch Health Companies Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.00 and a Current Ratio set at 1.20.


The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BHC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Bausch Health Companies Inc. go to 8.70%.

Bausch Health Companies Inc. [BHC] Insider Position Details

There are presently around $2,814 million, or 66.80% of BHC stock, in the hands of institutional investors. The top three institutional holders of BHC stocks are: ICAHN CARL C with ownership of 34,721,118, which is approximately 0% of the company’s market cap and around 2.30% of the total institutional ownership; PAULSON & CO. INC., holding 25,839,035 shares of the stock with an approximate value of $280.1 million in BHC stocks shares; and NOMURA HOLDINGS INC, currently with $205.85 million in BHC stock with ownership of nearly 23.485% of the company’s market capitalization.

Positions in Bausch Health Companies Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 181 institutional holders increased their position in Bausch Health Companies Inc. [NYSE:BHC] by around 25,025,892 shares. Additionally, 170 investors decreased positions by around 30,275,408 shares, while 81 investors held positions by with 204,263,607 shares. The mentioned changes placed institutional holdings at 259,564,907 shares, according to the latest SEC report filing. BHC stock had 61 new institutional investments in for a total of 6,110,191 shares, while 61 institutional investors sold positions of 10,958,955 shares during the same period.